Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 vs Olmesartan in Japanese Patients with Essential Hypertension
NCT01599104Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2012
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in essential hypertension, sponsored by Novartis. Started Jun 2012; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01599104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01599104.